HGEN Insider Trading Activity and SEC Form 4 Filings
HGEN insider trading summary
No open-market insider purchases or sales of Humanigen, Inc (HGEN) have been reported on SEC Form 4 in the past 12 months.
Latest HGEN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 18, 2023 | Black Horse Capital Management LLC | Insider | Sell | $835 (75,887 @ $0.01) |
| Oct 18, 2023 | Dale Chappell | Chief Scientific Officer | Sell | $835 (75,887 @ $0.01) |
| Oct 18, 2023 | Dale Chappell | Chief Scientific Officer | Sell | $3K (276,210 @ $0.01) |
| Oct 18, 2023 | Dale Chappell | Chief Scientific Officer | Sell | $377 (34,253 @ $0.01) |
| Oct 18, 2023 | Black Horse Capital Management LLC | Insider | Sell | $377 (34,253 @ $0.01) |
| Oct 18, 2023 | Black Horse Capital LP | Insider | Sell | $377 (34,253 @ $0.01) |
| Oct 18, 2023 | Cheval Holdings, Ltd. | Insider | Sell | $377 (34,253 @ $0.01) |
| Oct 18, 2023 | Black Horse Capital Master Fund Ltd. | Insider | Sell | $377 (34,253 @ $0.01) |
| Oct 18, 2023 | Black Horse Capital Master Fund Ltd. | Insider | Sell | $835 (75,887 @ $0.01) |
| Oct 18, 2023 | Black Horse Capital LP | Insider | Sell | $3K (276,210 @ $0.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.